Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) Equity Average (2020 - 2026)

Sight Sciences has reported Equity Average over the past 6 years, most recently at $64.1 million for Q4 2025.

  • For Q4 2025, Equity Average fell 29.73% year-over-year to $64.1 million; the TTM value through Dec 2025 reached $64.1 million, down 29.73%, while the annual FY2025 figure was $75.7 million, 27.09% down from the prior year.
  • Equity Average for Q4 2025 was $64.1 million at Sight Sciences, down from $67.2 million in the prior quarter.
  • Over five years, Equity Average peaked at $222.0 million in Q1 2022 and troughed at -$181.6 million in Q3 2021.
  • A 5-year average of $81.4 million and a median of $101.9 million in 2024 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: crashed 138.99% in 2021 and later soared 2501.15% in 2022.
  • Year by year, Equity Average stood at -$6.9 million in 2021, then soared by 2501.15% to $166.5 million in 2022, then dropped by 25.74% to $123.6 million in 2023, then decreased by 26.21% to $91.2 million in 2024, then dropped by 29.73% to $64.1 million in 2025.
  • Business Quant data shows Equity Average for SGHT at $64.1 million in Q4 2025, $67.2 million in Q3 2025, and $73.8 million in Q2 2025.